Kabar
Development of new vaccines is eyed in Kazakhstan, General Director of the Research Institute of Biological Safety Problems Kunsulu Zakaria said Tuesday, Kazinform correspondent reports. At the session of the Kazakh Government, Ms Zakaria revealed researchers of the institute had developed over 70 types of domestic vaccines and biological medical products against especially dangerous infections. Presently, according to Kunsulu Zakaria, the Research Institute of Biological Safety Problems focuses on two sci-tech programs, including the development of a vaccine against COVID-19 and the country’s biological safety. In addition, six grant projects are being implemented within the framework of grant funding.
Kunsulu Zakaria added that implementation of the projects within the programs had already resulted in 19 patents and 46 articles published in international research magazines.
